Pomdoctor FY25 net loss widens to RMB 130.93 million; net revenues rise 16.7% to RMB 399.92 million

• Pomdoctor fiscal 2025 net loss widened to RMB 130.93 million, operating loss widened to RMB 118.64 million.
• Net revenues rose 16.7% to RMB 399.92 million, led by a 69.3% climb in internet hospital revenue to RMB 150.71 million.
• Gross profit increased to RMB 52.28 million, while gross margin slipped 0.8 percentage points to 13.1%.
• Sales and marketing expenses rose 70.7% to RMB 96.21 million, due to higher outsourced promotion costs and higher doctor service fees and staff costs tied to internet hospital growth.
• General and administrative expenses surged to RMB 59.73 million, due to higher investor-relations consulting fees and IPO-related consulting and office costs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-056576), on May 14, 2026, and is solely responsible for the information contained therein.